Learn ·

How to Read a Peptide Certificate of Analysis (COA)

Purity, identity, and the numbers that do not appear: what an HPLC/MS certificate actually tells you about the vial in your hand.

Published Sep 20, 2026

A certificate of analysis answers two questions about a lot of peptide: is it the right molecule (identity, by mass spectrometry) and how much of what is in the vial is that molecule (purity, by HPLC). A good COA also tells you which lot it belongs to, which laboratory ran the tests, and by what method. What it usually does not tell you is how many milligrams of peptide are actually in the vial, whether the contents are sterile, or whether the peptide is biologically active — and knowing those limits is most of what it means to read a COA well. Ours are posted on each product page (the “Additional information” tab) and the testing program is described on the Lab Testing page.

What is on a COA

Field What it means What to check
Product name, sequence, formula, molecular weight Identifies the molecule the certificate is about. The molecular weight should match the published value for that peptide (for a salt form, note the counter-ion).
Lot / batch number Ties the certificate to a specific production run. Must match the lot printed on your vial. A COA without a lot number certifies nothing in particular.
Appearance Usually “white lyophilized powder”. Cosmetic; cake shape varies with the freeze-drying cycle and is not a quality signal.
Purity (RP-HPLC) Percentage of the UV-absorbing material in the sample that is the main peak. Method details — column, gradient, wavelength — and ideally the chromatogram itself.
Identity (MS) The measured mass compared with the theoretical mass. Agreement within about 1 Da (allowing for the charge state and isotope pattern).
Water content, counter-ion content, net peptide content How much of the vial’s mass is actually peptide. Often absent on research-grade COAs; see below.
Endotoxin, sterility, bioburden Microbiological quality. Rarely present unless the lot was made to a pharmaceutical standard.

HPLC purity: what the number means

Reversed-phase HPLC separates the sample into peaks by hydrophobicity and measures each peak’s UV absorbance, usually at 214–220 nm where the peptide backbone absorbs. “Purity 99.2%” means the main peak accounted for 99.2% of the total peak area. Everything else in the chromatogram is an impurity of some kind, and in a synthetic peptide they are predictable: deletion sequences (one residue missed during synthesis), truncated sequences, peptides with a protecting group still attached, oxidized (+16 Da) and deamidated (+1 Da) variants, and diastereomers from racemization during coupling. The 2014 review by D’Hondt and colleagues catalogues these systematically.

Two limits are worth knowing. Area percent assumes every impurity absorbs UV like the parent peptide, which is not exactly true; an impurity lacking an aromatic residue, for instance, can be under-counted, which is why regulators increasingly ask for relative response factors. And a chromatogram can only show what the method separates: a diastereomer or a deamidated variant may co-elute with the main peak on a routine gradient, so two competent laboratories running different methods can legitimately report different purities for the same lot.

Mass spectrometry: identity, not purity

Electrospray mass spectrometry measures the mass of the main component. For a peptide of a few thousand daltons the instrument sees multiply charged ions — [M+2H]2+, [M+3H]3+ and so on — and the software deconvolutes them to a single molecular mass. Agreement with the theoretical mass to within about a dalton confirms that the sequence is (almost certainly) the intended one and that nothing has been added or lost. It does not measure purity: a sample that is 80% peptide can produce a perfect mass spectrum. Read the MS result and the HPLC result as answering different questions.

Purity is not the same as peptide content

This is the point most often misunderstood. HPLC purity describes the peptide fraction of the sample; it says nothing about how much of the powder’s mass is peptide at all. A lyophilized peptide typically carries several percent water and, more significantly, a counter-ion: synthetic peptides are purified by HPLC in trifluoroacetic-acid mobile phases, and the basic residues (lysine, arginine, histidine, the N-terminus) each retain a trifluoroacetate ion. TFA commonly accounts for 10% or more of the mass, and more still for lysine- or arginine-rich sequences. The result is that a “10 mg” vial at “99% purity” usually contains something like 7–9 mg of actual peptide — the net peptide content — and a COA that does not report peptide content leaves you to estimate it.

For most research this does not matter; concentrations are relative and the same lot is used throughout. It matters when absolute concentration is critical, and it matters in cell-based assays, where trifluoroacetate itself has been shown to alter cell proliferation at the concentrations that come along with a TFA-salt peptide. In those cases the options are to request peptide-content data, or to specify an acetate salt, which exchanges the counter-ion.

What is usually not on a COA

  • Endotoxin and sterility. Research-grade peptides are not sterile pharmaceuticals and are not tested as such unless stated. For cell culture, sterile-filter the reconstituted solution.
  • Biological activity. Chemical identity and purity do not guarantee the peptide is folded or active; that is established in an assay.
  • Residual solvents and heavy metals. Part of a pharmaceutical specification, rarely of a research one.
  • Stability data. The COA describes the lot on the day it was tested. What happens afterward is up to storage (see How to store peptides).

Red flags

  • No lot number, or a lot number that does not match the vial.
  • No method details — no column, gradient, wavelength or instrument — and no chromatogram image.
  • Purity reported to two or three decimal places with no supporting data, or an identical “99.9%” on every product a vendor sells.
  • A molecular weight that does not match the peptide, or a mass spectrum that does not match the stated molecular weight.
  • A certificate with no laboratory name, or one issued by the seller with no independent testing behind it. “Third-party tested” should mean an identifiable independent laboratory.
  • A certificate that is older than the product line — i.e., one representative COA reused for every subsequent lot.

Matching a COA to your vial

Read the lot number on the vial label, open the product’s COA, and confirm the lots agree. Then check the three things that matter: the molecular weight matches the peptide, the MS result matches that weight, and the HPLC purity is what the listing claims. If the certificate reports peptide content, use that figure — not the label mass — for any calculation where absolute concentration matters (the reconstitution guide covers the arithmetic).

Frequently asked questions

Straight answers to the questions researchers most often ask. Everything below summarizes published preclinical and clinical literature; it is not medical advice, and these compounds are supplied for laboratory research only.

What is a good purity for a research peptide?

Most research-grade peptides are specified at ≥95% by HPLC, and ≥98–99% is typical for well-made short peptides. Demanding applications — receptor-binding assays, quantitative work — benefit from the higher figure. Purity above about 99% offers diminishing returns for most laboratory uses.

What is the difference between purity and peptide content?

Purity (HPLC) is the fraction of the peptide material that is the intended sequence. Peptide content is the fraction of the powder's total mass that is peptide at all, after subtracting water and counter-ions such as trifluoroacetate. A 99%-pure peptide may be only 75–90% peptide by mass.

What is TFA and why is it in my peptide?

Trifluoroacetic acid is used in the HPLC purification of synthetic peptides, and each basic residue retains a trifluoroacetate counter-ion in the final lyophilized product. It is normal, it affects the net peptide content, and at the concentrations that accompany a TFA-salt peptide it can influence cell-based assays; acetate salts are the usual alternative for cell work.

Does a COA prove a peptide is sterile?

No, unless sterility or endotoxin testing is explicitly listed. Research-grade COAs report chemical identity and purity. Solutions intended for cell culture should be sterile-filtered.

Can I trust a COA issued by the seller?

An in-house certificate is only as good as the laboratory behind it. The standard to look for is testing by an identifiable independent laboratory, with method details and the chromatogram, tied to the specific lot on your vial.

What does HPLC stand for?

High-performance liquid chromatography. For peptides it is almost always reversed-phase HPLC, which separates components by hydrophobicity and measures them by UV absorbance, giving the purity figure on the certificate.

Why do two labs report different purities for the same peptide?

Different columns, gradients and wavelengths separate impurities differently, and area-percent purity assumes every component absorbs UV equally, which is not exactly true. Small differences between competent laboratories are normal; large ones deserve an explanation.

Where are Saltair's COAs?

On each product page under the "Additional information" tab, with the testing program described on the Lab Testing page. A few recently added products are marked "COA coming soon" while their independent testing completes.

References

  1. D'Hondt M, Bracke N, Taevernier L et al. Related impurities in peptide medicines Journal of pharmaceutical and biomedical analysis, 2014Systematic catalogue of synthesis- and degradation-related peptide impurities.
  2. Kumar Kuril A The Critical Need for Implementing RRF in the Accurate Assessment of Impurities in Peptide Therapeutics Analytical chemistry, 2025Why area-percent purity can under- or over-count impurities.
  3. Badgujar D, Paritala ST, Matre S et al. Enantiomeric purity of synthetic therapeutic peptides: A review Chirality, 2024Diastereomeric impurities that routine HPLC may not resolve.
  4. Bray BL Large-scale manufacture of peptide therapeutics by chemical synthesis Nature reviews. Drug discovery, 2003Solid-phase synthesis, HPLC purification and the origin of TFA salts.
  5. Cornish J, Callon KE, Lin CQ et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes The American journal of physiology, 1999Why the counter-ion matters in cell-based assays.
  6. Manning MC, Chou DK, Murphy BM et al. Stability of protein pharmaceuticals: an update Pharmaceutical research, 2010The degradation products (oxidation, deamidation) a COA's chromatogram may show.